Complement activating properties of monoreactive and polyreactive IgM rheumatoid factors

Area of Science:

• Immunology
• Rheumatology

Background:

• Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation.
• IgM rheumatoid factors (RFs) are autoantibodies implicated in RA pathogenesis.
• The complement system plays a role in RA inflammation.

Purpose of the Study:

• To compare the complement-activating properties of different types of IgM rheumatoid factors (monoclonal, monoreactive, and polyreactive).
• To investigate the potential pathogenic role of IgM RFs in rheumatoid arthritis.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was employed to measure complement activation.
• Classical complement pathway activation was assessed by binding IgM RF to IgG Fc and reacting with human serum.
• Complement activation was quantified by measuring C4 binding relative to IgM RF binding.

Main Results:

• Monoreactive IgM rheumatoid factor demonstrated approximately three times higher complement-activating potential compared to polyreactive IgM rheumatoid factor.
• This indicates a differential capacity of IgM RF subtypes to activate the complement cascade.

Conclusions:

• Monoreactive IgM RFs, with their enhanced complement-activating ability, may contribute more significantly to complement-dependent inflammation in RA.
• These findings suggest that monoreactive IgM RFs could play a more critical pathogenic role in rheumatoid arthritis than polyreactive IgM RFs.